Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2020

Jan 15, 2020

30198_dirs_2020-01-15_7724915b-5e47-4768-8800-ec3da74aee08.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-01-13

Reporting Person: SAYER KEVIN R (Director, President, CEO and Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-01-13 Common Stock S 247 $224.764 Disposed 202690 Direct
2020-01-13 Common Stock S 272 $225.4584 Disposed 202418 Direct
2020-01-13 Common Stock S 132 $226.205 Disposed 202286 Direct
2020-01-13 Common Stock S 743 $227.7577 Disposed 201543 Direct
2020-01-13 Common Stock S 1189 $228.6237 Disposed 200354 Direct
2020-01-13 Common Stock S 78 $229.28 Disposed 200276 Direct
2020-01-13 Common Stock S 260 $230.47 Disposed 200016 Direct
2020-01-13 Common Stock S 1720 $232.7174 Disposed 198296 Direct
2020-01-13 Common Stock S 1139 $233.6895 Disposed 197157 Direct
2020-01-13 Common Stock S 220 $235.0 Disposed 196937 Direct

Footnotes

F1: On May 15, 2019, Mr. Sayer adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Sayer. The shares set forth above were sold pursuant to the 10b5-1 Plan.

F2: This transaction was executed in multiple trades at prices ranging from $224.12 to $225.05. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F3: Included in this number are 89,648 unvested restricted stock units, 35,829 of which were granted on March 8, 2019 and shall vest through March 8, 2022, 40,272 of which were granted on March 8, 2018 and shall vest through March 8, 2021, 13,547 of which were granted on March 8, 2017 and shall vest through March 8, 2020.

F4: This transaction was executed in multiple trades at prices ranging from $225.15 to $225.84. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F5: This transaction was executed in multiple trades at prices ranging from $226.15 to $226.21. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F6: This transaction was executed in multiple trades at prices ranging from $227.20 to $228.10. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F7: This transaction was executed in multiple trades at prices ranging from $228.22 to $229.21. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F8: This transaction was executed in multiple trades at prices ranging from $232.29 to $233.20. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

F9: This transaction was executed in multiple trades at prices ranging from $233.29 to $234.20. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.